Home › Funds › Renaissance Technologies › NMRA
Renaissance Technologies position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)1.26M sh
Reported value held$2.15M
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 13.60K | $232 | New |
| Q1 2024 | 138.90K | $1.91K | Add |
| Q1 2025 | 1.26M | $1.26M | New |
| Q1 2025 | 1.26M | $1.26M | New |
| Q2 2025 | 1.43M | $1.05M | Add |
| Q2 2025 | 1.43M | $1.05M | Add |
| Q3 2025 | 1.16M | $2.12M | Reduce |
| Q4 2025 | 1.45M | $2.59M | Add |
| Q1 2026 | 1.39M | $2.71M | Reduce |
| Q2 2026 | 1.26M | $2.15M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026
- Goldman Sachs Group 303.86K sh · $516.57K · Q2 2026